Comparison of Long-term Response and Remission to Omalizumab and Anti-IL-5/IL-5R Using Different Criteria in a Real-life Cohort of Severe Asthma Patients

Valverde-Monge, Marcela; Sánchez-Carrasco, Patricia; Betancor, Diana; Barroso, Blanca; Rodrigo-Muñoz, José Manuel; Mahillo-Fernández, Ignacio; Arismendi, Ebymar; Bobolea, Irina; Cárdaba, Blanca; Cruz, María Jesús; Del Pozo, Victoria; Domínguez-Ortega, Javier; González-Barcala, Francisco Javier; Olaguibel, José María; Luna-Porta, Juan Alberto; Martínez-Rivera, Carlos; Mullol, Joaquim; Muñoz, Xavier; Peleteiro-Pedraza, Lorena; Picado Valles, Cesar; Plaza, Vicente; Quirce, Santiago; Rial, Manuel Jorge; Soto-Retes, Lorena; Valero, Antonio; Sastre, Joaquín

doi:10.1016/j.arbres.2023.11.011

Archivos de Bronconeumología

2024

DOI: 10.1016/j.arbres.2023.11.011

|View full text |Cite

Comparison of Long-term Response and Remission to Omalizumab and Anti-IL-5/IL-5R Using Different Criteria in a Real-life Cohort of Severe Asthma Patients

Marcela Valverde-Monge,

Patricia Sánchez-Carrasco,

Diana Betancor

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

2025

Publication Types

Select...

Article5

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 8 publications

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Identifying super-responders

Mailhot-Larouche,

Celis-Preciado,

Heaney

et al. 2025

Annals of Allergy, Asthma & Immunology

View full text Add to dashboard Cite

Identifying super-responders

Mailhot-Larouche,

Celis-Preciado,

Heaney

et al. 2025

Annals of Allergy, Asthma & Immunology

View full text Add to dashboard Cite

Early Treatment Response to Mepolizumab Predicts Clinical Remission in Severe Eosinophilic Asthma

Hamada,

Gibson,

Harvey

et al. 2024

The Journal of Allergy and Clinical Immunology: In Practice

View full text Add to dashboard Cite

Clinical remission attainment, definitions, and correlates among patients with severe asthma treated with biologics: a systematic review and meta-analysis

Shackleford,

Heaney,

Redmond

et al. 2024

The Lancet Respiratory Medicine

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Comparison of Long-term Response and Remission to Omalizumab and Anti-IL-5/IL-5R Using Different Criteria in a Real-life Cohort of Severe Asthma Patients

Cited by 8 publications

References 24 publications

Identifying super-responders

Identifying super-responders

Early Treatment Response to Mepolizumab Predicts Clinical Remission in Severe Eosinophilic Asthma

Clinical remission attainment, definitions, and correlates among patients with severe asthma treated with biologics: a systematic review and meta-analysis

Contact Info

Product

Resources

About